Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism.

Agarwal P, Hogarth P, Hayflick S, MacLeod P, Kuriakose R, McKenzie J, Heffernan N, Dinelle K, Sossi V, Stoessl AJ.

Mov Disord. 2012 Nov;27(13):1698-9. doi: 10.1002/mds.25160. No abstract available.

PMID:
23192926
2.
3.

Molecular imaging studies in Parkinson disease: reducing diagnostic uncertainty.

Felicio AC, Shih MC, Godeiro-Junior C, Andrade LA, Bressan RA, Ferraz HB.

Neurologist. 2009 Jan;15(1):6-16. doi: 10.1097/NRL.0b013e318183fdd8. Review.

PMID:
19131852
4.

Early-onset autosomal-recessive parkinsonian-pyramidal syndrome.

Lai HJ, Lin CH, Wu RM.

Acta Neurol Taiwan. 2012 Sep;21(3):99-107. Review.

5.

Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes.

Pal PK, Wszolek ZK, Uitti R, Markopoulou K, Calne SM, Stoessl AJ, Calne DB.

Parkinsonism Relat Disord. 2001 Sep;8(1):51-6. Review.

PMID:
11472880
6.

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

Mallat Z, Lambeau G, Tedgui A.

Circulation. 2010 Nov 23;122(21):2183-200. doi: 10.1161/CIRCULATIONAHA.110.936393. Review. No abstract available.

Supplemental Content

Support Center